课题基金 / 基金详情

BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES

BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
BAPP 和朊病毒转染的人体肌肉培养物
批准号:
2609681
负责人:
VALERIE ASKANAS
金额:
$26.73万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-12-01 至 1999-11-30

项目摘要

项目成果

VALERIE ASKANAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this proposal, utilizing infection of cultured human muscle with BetaAPP or PrPC genes in adenovirus vector, we will pursue the following aims: Aim 1. Determine whether long-term overexpression of BetaAPP or PrPc genes in normal human muscle cultured i) aneurally and ii) innervated, using adenovirus vector, will induce the IBM-phenotype, including a) vacuolization and the other aspects of IBM muscle degeneration b) PHFs, c) congophilic amyloid deposits and d) accumulation of the other IBM- characteristic proteins. Aim 2. Determine whether increased ApoE in the muscle fiber (either by genetic overexpression through an adenovirus vector or by increased exposure from the culture medium) will facilitate development of the IBM phenotype in cultured normal human muscle concurrent with Beta APP and/or PrPc gene overexpression. Aim 3A. Determine whether challenging cultured h-IBM muscle aneurally or innervated with extra copies of the BetaAPP or PrPc gene will accelerate coordinated development in them of the IBM-phenotype and aggravate its severity, as compared to a) cultured uninfected h-IBM muscle and b) normal cultured human muscle with concurrently overexpressed BetaAPP and PrPc. (This is necessary because cultured uninfected h-IBM muscle fibers express some aspects of the IBM phenotype including increased accumulation of BetaAPP and PrPc, but this is present only in 20-40% of the muscle fibers at any given time -the severely affected fibers are dying while others do not yet express the phenotype). Aim 3B. Determine whether accumulation of ApoE (either by genetic expression thru an adenovirus vector or by exposure from the culture medium) will facilitate development of the IBM phenotype in cultured h-IBM muscle fibers without and with overexpressed BetaAPP or PrPc in them. Aim 3C. Determine whether infection of cultured h-IBM with adenovirus carrying BetaAPP or PrPc cDNA in antisense orientation will inhibit manifestation of the IBM phenotype. The broad objectives of our research are to better understand a) molecular mechanisms leading to increased accumulation in h- and s-IBM of a group of proteins that are normally not expressed extrajunctionally in adult human muscle, and b) their role in the disease process. Our long-term coals are to learn the molecular pathogenic mechanisms leading to h- and s-IBM which could eventually lead to treatment.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/1531-8249(200004)47:4
发表时间: 2000-04-01
期刊: ANNALS OF NEUROLOGY
影响因子: 11.2
作者: [Askanas, V, Engel, WK, Vidal, R]
通讯作者: Vidal, R
Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.
包涵体肌炎:发病机制的最新概念以及与衰老和阿尔茨海默病的关系。
DOI: 10.1093/jnen/60.1.1
发表时间: 2001
期刊: Journal of neuropathology and experimental neurology
影响因子: 3.2
作者: [Askanas,V, Engel,WK]
通讯作者: Engel,WK
Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging.
包涵体肌炎和肌病的展开故事:错误折叠蛋白质、β-淀粉样蛋白、胆固醇和衰老的作用。
DOI: 10.1177/08830738030180030401
发表时间: 2003
期刊: Journal of child neurology
影响因子: 1.9
作者: [Askanas,Valerie, Engel,WKing]
通讯作者: Engel,WKing
Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.
活性细胞外信号调节蛋白激酶与包涵体肌炎肌肉的成对螺旋丝的关联表明其在包涵体肌炎 tau 磷酸化中的作用。
DOI: 10.1016/s0002-9440(10)65056-0
发表时间: 2000
期刊: The American journal of pathology
影响因子: --
作者: [Wilczynski,GM, Engel,WK, Askanas,V]
通讯作者: Askanas,V
6
    ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
    ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
    ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
    ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
    海外基金